Stockreport

MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site [Yahoo! Finance]

MIRA Pharmaceuticals, Inc.  (MIRA) 
PDF Netherlands, as the site for its Phase I/IIa clinical trial of Ketamir-2. (Source: 'MIRA Accelerates Toward Becoming a Clinical-Stage Company...') The Phase I/IIa tria [Read more]